Together, these data implicate leptin and LEPR pathway in ALL regulation and highlight how targeting leptin‐producing adipocytes and/or the leptin‐LEPR pathway (e.g. through medical mimics of the fasting response)82 may be beneficial in suppressing ALL growth). The gene discussed is LEP; the disease is acute lymphoblastic leukemia.